Reverse causality in Empa-Reg Outcome: The proverbial elephant?

被引：2
|
作者：
Rajput, Rajesh [1 ]
Ved, Jignesh [2 ]
机构：
[1] Pandit Bhagwat Dayal Sharma Post Grad Inst Med Sc, Dept Endocrinol, Rohtak 124001, Haryana, India
[2] Boehringer Ingelheim India Pvt Ltd, Med Affairs, 10th Floor,Hallmark Plaza, Bombay 400051, Maharashtra, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2017年 / 127卷
关键词：
CARDIOVASCULAR OUTCOMES; BLOOD-PRESSURE; RISK; MORTALITY; DISEASE;
D O I：
10.1016/j.diabres.2016.12.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [1] EMPA-REG OUTCOME: The Endocrinologist's Point of View
    Perreault, Leigh
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06) : S51 - S56
  • [2] EMPA-REG OUTCOME: The Cardiologist's Point of View
    Pham, Son V.
    Chilton, Robert J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01) : S53 - S58
  • [3] EMPA-REG OUTCOME: The Cardiologist's Point of View
    Pham, Son V.
    Chilton, Robert
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06) : S57 - S62
  • [4] Asian Perspective of the EMPA-REG OUTCOME Study
    Bando, Yasuko K.
    Murohara, Toyoaki
    CIRCULATION JOURNAL, 2017, 81 (02) : 155 - 157
  • [5] Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial
    Fitchett, David
    Inzucchi, Silvio E.
    Zinman, Bernard
    Wanner, Christoph
    Schumacher, Martin
    Schmoor, Claudia
    Ohneberg, Kristin
    Ofstad, Anne Pernille
    Salsali, Afshin
    George, Jyothis T.
    Hantel, Stefan
    Bluhmki, Erich
    Lachin, John M.
    Zannad, Faiez
    ESC HEART FAILURE, 2021, 8 (06): : 4517 - 4527
  • [6] EMPA-REG OUTCOME: The Endocrinologist's Point of View
    Perreault, Leigh
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01) : S48 - S52
  • [7] EMPA-REG OUTCOME: The Nephrologist's Point of View
    Wanner, Christoph
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (01) : S59 - S67
  • [8] EMPA-REG OUTCOME: The Nephrologist's Point of View
    Wanner, Christoph
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06) : S63 - S72
  • [9] Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial
    Alzaid, Aus
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (06) : 324 - 327
  • [10] Series: Cardiovascular outcome trials for diabetes drugs Empagliflozin and EMPA-REG OUTCOME
    Fisher, Miles
    BRITISH JOURNAL OF DIABETES, 2020, 20 (02): : 138 - 141
12345